This inventor holds 1 USPTO granted patent and 3 published patent applications and 4 EPO patents. Top assignee: Gilupi Gmbh. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovations by Thomas Brandstetter in Target Structure Enrichment
Introduction: Thomas Brandstetter, an inventive mind hailing from Freiburg, Germany, has made significant contributions to the field of biomedical engineering with his innovative patent. With a keen focus on enhancing methodologies in both in-vivo and in-vitro environments, Brandstetter's work aims to streamline the process of enriching target structures in diverse sample liquids.
Latest Patents: Thomas Brandstetter holds a notable patent titled "Device for the in-vivo and/or in-vitro enrichment of target structures in a sample liquid." This device is designed with at least one functional portion equipped with receptors specifically aimed at enriching target structures. A unique feature of this invention is the helical shape of the functional portion, which is achieved by twisting a symmetrical starting cross section around a twisting axis. This innovative design enhances the enrichment efficiency of the target structures in sample liquids, representing a significant step forward in the field.
Career Highlights: Working at Gilupi GmbH, Thomas Brandstetter has positioned himself at the forefront of innovative solutions in biomedical applications. His expertise and dedication to advancing technologies have led to the creation of his patent, showcasing his commitment to improving scientific methods and tools.
Collaborations: Brandstetter has collaborated with notable colleagues Robert Niestroj-Pahl and Klaus Lücke, further enhancing the scope and impact of his work. Their collective expertise fosters a dynamic environment that promotes innovation and development in their projects.
Conclusion: Thomas Brandstetter's inventive solutions and collaboration with his peers highlight the importance of continuous innovation in the biomedical field. His patent not only exemplifies his creativity but also contributes substantially to enhancing the methodologies used in target structure enrichment, promising advancements for future applications in science and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile